Cargando…
Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus
Diverse pathogenic agents often utilize overlapping host networks, and hub proteins within these networks represent attractive targets for broad-spectrum drugs. Using bacterial toxins, we describe a new approach for discovering broad-spectrum therapies capable of inhibiting host proteins that mediat...
Autores principales: | Leonardi, William, Zilbermintz, Leeor, Cheng, Luisa W., Zozaya, Josue, Tran, Sharon H., Elliott, Jeffrey H., Polukhina, Kseniya, Manasherob, Robert, Li, Amy, Chi, Xiaoli, Gharaibeh, Dima, Kenny, Tara, Zamani, Rouzbeh, Soloveva, Veronica, Haddow, Andrew D., Nasar, Farooq, Bavari, Sina, Bassik, Michael C., Cohen, Stanley N., Levitin, Anastasia, Martchenko, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043268/ https://www.ncbi.nlm.nih.gov/pubmed/27686742 http://dx.doi.org/10.1038/srep34475 |
Ejemplares similares
-
Cross-inhibition of pathogenic agents and the host proteins they exploit
por: Zilbermintz, Leeor, et al.
Publicado: (2016) -
Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting
por: Zilbermintz, Leeor, et al.
Publicado: (2015) -
Identification of Bithionol, Dichlorophen, and Miconazole
as Antibacterial Agents against Acinetobacter calcoaceticus
por: Khaw, Tiffany H., et al.
Publicado: (2020) -
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
por: Kim, Kevin, et al.
Publicado: (2015) -
Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
por: Ayyagari, Vijayalakshmi N, et al.
Publicado: (2014)